Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Menopausal disorders and other disorders in the perimenopausal period”

This protocol was developed on the basis of clinical guideline “Menopausal disorders and other in perimenopausal period”, which is based principles evidence-based medicine takes into account Recommendations Women’s Midlife Health Menopause Hormone Therapy, 2016 by specialists International Society (IMS), corresponds to specifics providing medical care our country.Also, international guidelines menopause issues were used development this protocol, such as: “Menopause: diagnosis management” National Institute for Care Excellence (NICE) guideline, 2019; сlinical guidance “Managing menopausal symptoms” Royal Australian New Zealand College Obstetricians Gynaecologists (RANZCOG), 2020; “The genitourinary syndrome menopause” North American Society, (NAMS), British (BMS) & Concern (WHC) recommendations hormone replacement therapy women, 2020.The goal protocol: ensure organization care, establish uniform requirements treatment patients with symptoms, recommend use STRAW+10 (2011) criteria all health professionals.The describes at levels – from primary tertiary care. Detailed information category presented. Special attention paid therapy, taking its possible risks.The intended general practitioners family doctors, obstetrician-gynecologists, gynecological oncologists, oncological surgeons, cardiologists, endocrinologists, orthopedic traumatologists professionals who provide assistance women disorders.